Feng, Y., Fan, M., Slotnick, N., Su, J., Huang, P., Liu, J., He, W. (2025). A first-in-class KIF11 degrader antibody conjugate (DAC) as a potential therapy targeting a broad spectrum of cancers.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3092